Parties Brief Federal Circuit In Dispute Over Gene Modification Patent

Mealey's (October 30, 2017, 12:56 PM EDT) -- WASHINGTON, D.C. — In an Oct. 25 appellee brief filed with the Federal Circuit U.S. Court of Appeals, a genomic research center argued that an appeal of a Patent Trial and Appeal Board (PTAB) interference proceeding stemming from technology related to genetic modification should be dismissed for lack of appellate jurisdiction (Regents of the University of California, et al., v. The Broad Institute Inc., et al., No. 17-1907, Fed. Cir.)....